Based on existing studies, it is found that the abnormal expression of S100P is associated with a variety of tumors, and increased S100P expression is related to poor prognosis.30,31 Cong et al32 found that in breast cancer, S100P promotes tumor progression but enhances chemosensitivity. The gene discussed is S100P; the disease is breast cancer.